These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36780768)

  • 1. Community selected strategies to reduce opioid-related overdose deaths in the HEALing (Helping to End Addiction Long-term
    Chandler R; Nunes EV; Tan S; Freeman PR; Walley AY; Lofwall M; Oga E; Glasgow L; Brown JL; Fanucchi L; Beers D; Hunt T; Bowers-Sword R; Roeber C; Baker T; Winhusen TJ
    Drug Alcohol Depend; 2023 Apr; 245():109804. PubMed ID: 36780768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Opioid-overdose Reduction Continuum of Care Approach (ORCCA): Evidence-based practices in the HEALing Communities Study.
    Winhusen T; Walley A; Fanucchi LC; Hunt T; Lyons M; Lofwall M; Brown JL; Freeman PR; Nunes E; Beers D; Saitz R; Stambaugh L; Oga EA; Herron N; Baker T; Cook CD; Roberts MF; Alford DP; Starrels JL; Chandler RK
    Drug Alcohol Depend; 2020 Dec; 217():108325. PubMed ID: 33091842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio.
    Young AM; Brown JL; Hunt T; Sprague Martinez LS; Chandler R; Oga E; Winhusen TJ; Baker T; Battaglia T; Bowers-Sword R; Button A; Fallin-Bennett A; Fanucchi L; Freeman P; Glasgow LM; Gulley J; Kendell C; Lofwall M; Lyons MS; Quinn M; Rapkin BD; Surratt HL; Walsh SL
    BMJ Open; 2022 Sep; 12(9):e059328. PubMed ID: 36123106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing perceived barriers to scaling up overdose education and naloxone distribution and medications for opioid use disorder in the United States in the HEALing (Helping End Addiction Long-Term®) communities study.
    Knudsen HK; Walker DM; Mack N; Kinnard EN; Huerta TR; Glasgow L; Gilbert L; Garner BR; Dasgupta A; Chandler R; Walsh SL; Tin Y; Tan S; Sprunger J; Sprague-Martinez L; Salsberry P; Saucier M; Rudorf M; Rodriguez S; Oser CB; Oga E; Nakayima J; Linas BS; Lefebvre RC; Kosakowski S; Katz RE; Hunt T; Holman A; Holloway J; Goddard-Eckrich D; Fareed N; Christopher M; Aldrich A; Adams JW; Drainoni ML
    Prev Med; 2024 Aug; 185():108034. PubMed ID: 38857770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HEALing (Helping to End Addiction Long-term
    HEALing Communities Study Consortium
    Drug Alcohol Depend; 2020 Dec; 217():108335. PubMed ID: 33248391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaling up overdose education and naloxone distribution in Kentucky: adoption and reach achieved through a "hub with many spokes" model.
    Knudsen HK; Freeman PR; Oyler DR; Oser CB; Walsh SL
    Addict Sci Clin Pract; 2023 Nov; 18(1):72. PubMed ID: 38031180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.
    Chhatwal J; Mueller PP; Chen Q; Kulkarni N; Adee M; Zarkin G; LaRochelle MR; Knudsen AB; Barbosa C
    JAMA Netw Open; 2023 Jun; 6(6):e2314925. PubMed ID: 37294571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting community-based naloxone distribution using opioid overdose death rates: A descriptive analysis of naloxone rescue kits and opioid overdose deaths in Massachusetts and Rhode Island.
    Zang X; Macmadu A; Krieger MS; Behrends CN; Green TC; Morgan JR; Murphy SM; Nolen S; Walley AY; Schackman BR; Marshall BD
    Int J Drug Policy; 2021 Dec; 98():103435. PubMed ID: 34482264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operationalizing and selecting outcome measures for the HEALing Communities Study.
    Slavova S; LaRochelle MR; Root ED; Feaster DJ; Villani J; Knott CE; Talbert J; Mack A; Crane D; Bernson D; Booth A; Walsh SL
    Drug Alcohol Depend; 2020 Dec; 217():108328. PubMed ID: 33091844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of opioid overdose education and naloxone distribution in New York City.
    Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
    Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
    [No Abstract]   [Full Text] [Related]  

  • 11. An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study.
    Wai JM; Blevins D; Hunt T; Gilbert L; Campbell ANC; Levin FR; El-Bassel N; Nunes E
    Psychiatr Serv; 2024 Jun; 75(6):580-588. PubMed ID: 38347814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder.
    Moffitt T; Fallin-Bennett A; Fanucchi L; Walsh SL; Cook C; Oller D; Ross A; Gallivan M; Lauckner J; Byard J; Wheeler-Crum P; Lofwall MR
    Front Public Health; 2024; 12():1334850. PubMed ID: 38425462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
    Alexander M; Hooker J; Stratton M; Huh M; Houck K
    J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug court utilization of medications for opioid use disorder in high opioid mortality communities.
    Marlowe DB; Theiss DS; Ostlie EM; Carnevale J
    J Subst Abuse Treat; 2022 Oct; 141():108850. PubMed ID: 35931014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.
    Pinkhover A; Celata K; Baker T; Chatterjee A; Lunze K
    Front Public Health; 2024; 12():1407522. PubMed ID: 38957203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties.
    Cerdá M; Hamilton AD; Hyder A; Rutherford C; Bobashev G; Epstein JM; Hatna E; Krawczyk N; El-Bassel N; Feaster DJ; Keyes KM
    Epidemiology; 2024 May; 35(3):418-429. PubMed ID: 38372618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction to the special issue on the HEALing Communities Study.
    El-Bassel N; Jackson RD; Samet J; Walsh SL
    Drug Alcohol Depend; 2020 Dec; 217():108327. PubMed ID: 33091843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-led approaches to making naloxone available in public settings: Implementation experiences in the HEALing communities study.
    Starbird LE; Onuoha E; Corry G; Hotchkiss J; Benjamin SN; Hunt T; Schackman BR; El-Bassel N
    Int J Drug Policy; 2024 Jun; 128():104462. PubMed ID: 38795466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local health departments and the implementation of evidence-based policies to address opioid overdose mortality.
    Feuerstein-Simon R; Lowenstein M; Sharma M; Dupuis R; Luna Marti X; Cannuscio CC
    Subst Abus; 2020; 41(4):468-474. PubMed ID: 32213045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.
    Walley AY; Xuan Z; Hackman HH; Quinn E; Doe-Simkins M; Sorensen-Alawad A; Ruiz S; Ozonoff A
    BMJ; 2013 Jan; 346():f174. PubMed ID: 23372174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.